Related Experiment Video
Updated: Mar 13, 2026
04:05
Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
Published on: July 5, 2024
802
[Biodegradable catheters and urinary stents. When?]
F Soria1, E Morcillo1, A López de Alda2
1Unidad de Endoscopia de la Fundación Centro de Cirugía de Mínima Invasión Jesús Usón. Cáceres. España.
Archivos Espanoles De Urologia
|October 12, 2016
Summary
Biodegradable urinary catheters and stents offer improved biocompatibility and controlled degradation, reducing complications like infection and morbidity. Ongoing bioengineering advances promise safer, more effective biodegradable devices for urological applications.
Area of Science:
- Biomaterials Science
- Urology
- Bioengineering
Background:
- Permanent urinary catheters and stents can cause adverse effects, device failure, and complications like forgotten catheter syndrome.
- There is a significant need for biodegradable alternatives to improve patient outcomes and reduce morbidity associated with urological devices.
Purpose of the Study:
- To review recent advances in biodegradable ureteral and urethral devices.
- To highlight challenges and future directions in developing safe and effective biodegradable urinary catheters and stents.
Main Methods:
- Development of novel biomaterials and copolymers for controlled degradation rates.
- Design modifications to ensure controlled, proximal-to-distal degradation and minimize fragmentation.
- Investigation of drug-eluting and biocoated stent technologies to mitigate adverse effects.
Main Results:
- Biodegradable materials allow programmable degradation times, enhancing biocompatibility and adaptation to urine.
- New designs facilitate controlled degradation, reducing fragmentation and potentially lowering risks of urinary tract infection and encrustation.
- While degradation is modulated, urothelial hyperplasia remains a challenge in biodegradable urethral stents.
Conclusions:
- Biodegradable urinary devices show promise in reducing catheter morbidity and adverse effects.
- Further bioengineering innovations, including drug-eluting and biocoated technologies, are crucial for overcoming challenges like urothelial hyperplasia.
- Advances in bioengineering are paving the way for safe and effective biodegradable solutions in urology.
